Literature DB >> 26482053

A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2.

Di Wu1, Hongwu Wang1, Weiming Yan1, Tao Chen1, Ming Wang1, Meifang Han1, Zeguang Wu1, Xiaojing Wang1, Guo Ai2, Dong Xi1, Guanxin Shen3, Xiaoping Luo2, Qin Ning4.   

Abstract

The underlying immune-mediated mechanisms involved in virus-induced severe hepatitis have not been well elucidated. In this study, we investigated the role of CD3(+)CD4(-)CD8(-) double-negative T (DN T) cells in the pathogenesis of fulminant viral hepatitis (FVH) induced by murine hepatitis virus strain 3 (MHV-3). After MHV-3 infection, the proportions of DN T cells increased significantly in BALB/cJ mice, and splenic DN T cells expressing high levels of CD69 were recruited by MHV-3-infected hepatocytes to the liver. Serum levels of alanine aminotransferase, aspartate aminotransferase and total bilirubin increased, accompanied by massive hepatocyte necrosis. These DN T cells were predominantly consisted of a TCRαβ(+) subset expressing high levels of CD44 and did not produce cytokine except IL-2. Adoptive transfer of this subset of DN T cells to the MHV-3-infected mice resulted in an increase in murine fibrinogen-like protein 2 (mfgl2) expressions in association with massive fibrin deposition in the liver. Following MHV-3 infection, membrane mfgl2 expression and functional procoagulant activity increased remarkably in the DN T cells. Introduction of a recombinant adenovirus which encoded a microRNA specifically targeting mfgl2 gene (Ad-mfgl2-miRNA) in vivo significantly inhibited the hepatic expression of mfgl2 and improved survival in mice. However, under this condition, adoptive transfer of the DN T cells accelerated the disease progression and reversed the benefit from mfgl2 gene silence, leading to a 100 % death rate. Our results demonstrate that DN T cells contribute to the outcome of MHV-3-induced FVH via an important effector molecule mfgl2.

Entities:  

Keywords:  CD4−CD8− double-negative T cells; Fulminant viral hepatitis; Murine fibrinogen-like protein 2; Murine hepatitis virus strain 3

Mesh:

Substances:

Year:  2016        PMID: 26482053     DOI: 10.1007/s12026-015-8727-0

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  49 in total

1.  Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression.

Authors:  Z X Zhang; L Yang; K J Young; B DuTemple; L Zhang
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

4.  C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.

Authors:  Gui-lian Xu; Jian Chen; Fei Yang; Gui-qing Li; Li-xin Zheng; Yu-zhang Wu
Journal:  Hepatology       Date:  2014-05-28       Impact factor: 17.425

Review 5.  Immunology of hepatitis B infection.

Authors:  Maria-Christina Jung; Gerd R Pape
Journal:  Lancet Infect Dis       Date:  2002-01       Impact factor: 25.071

6.  Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3 (MHV-3) infection.

Authors:  J W Ding; Q Ning; M F Liu; A Lai; K Peltekian; L Fung; C Holloway; H Yeger; M J Phillips; G A Levy
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

7.  CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.

Authors:  Yanmei Han; Qiuli Guo; Minggang Zhang; Zhubo Chen; Xuetao Cao
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

8.  Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells.

Authors:  F Erard; M T Wild; J A Garcia-Sanz; G Le Gros
Journal:  Science       Date:  1993-06-18       Impact factor: 47.728

9.  Pretransplant infusion of donor B cells enhances donor-specific skin allograft survival.

Authors:  Julia Gao; Megan S Ford McIntyre; Cheryl A D'Souza; Li Zhang
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

10.  Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.

Authors:  K Ando; T Moriyama; L G Guidotti; S Wirth; R D Schreiber; H J Schlicht; S N Huang; F V Chisari
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  3 in total

1.  Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.

Authors:  Hoang Van Tong; Nguyen Van Ba; Nghiem Xuan Hoan; Mai Thanh Binh; Dao Thanh Quyen; Ho Anh Son; Hoang Van Luong; Do Quyet; Christian G Meyer; Le Huu Song; Nguyen Linh Toan; Thirumalaisamy P Velavan
Journal:  BMC Infect Dis       Date:  2018-11-12       Impact factor: 3.090

2.  Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression.

Authors:  Haijing Yu; Yang Liu; Hongwu Wang; Xiaoyang Wan; Jiaquan Huang; Weiming Yan; Dong Xi; Xiaoping Luo; Guanxin Shen; Qin Ning
Journal:  Front Immunol       Date:  2018-12-13       Impact factor: 7.561

3.  Preclinical models of acute liver failure: a comprehensive review.

Authors:  Joshua Hefler; Braulio A Marfil-Garza; Rena L Pawlick; Darren H Freed; Constantine J Karvellas; David L Bigam; A M James Shapiro
Journal:  PeerJ       Date:  2021-12-09       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.